![](https://img.einnews.com/small/825463/myriad-genetics-lumea.jpeg)
Lumea and Myriad Genetics Collaborate to Enhance Access to Biomarker and Hereditary Cancer Tests in BxLink
Lumea and Myriad Genetics have partnered to integrate Myriad’s Prolaris® and MyRisk® molecular diagnostic tests into Lumea’s BxLink™ digital pathology platform. LEHI, UT, UNITED STATES, February 5, 2025 /EINPresswire.com/ -- Lumea Inc., a leader …